Cargando…
Alternative polyadenylation of ZEB1 promotes its translation during genotoxic stress in pancreatic cancer cells
Pancreatic ductal adenocarcinoma (PDAC) is characterized by extremely poor prognosis. The standard chemotherapeutic drug, gemcitabine, does not offer significant improvements for PDAC management due to the rapid acquisition of drug resistance by patients. Recent evidence indicates that epithelial-to...
Autores principales: | Passacantilli, Ilaria, Panzeri, Valentina, Bielli, Pamela, Farini, Donatella, Pilozzi, Emanuela, Fave, Gianfranco Delle, Capurso, Gabriele, Sette, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775412/ https://www.ncbi.nlm.nih.gov/pubmed/29120411 http://dx.doi.org/10.1038/cddis.2017.562 |
Ejemplares similares
-
Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells
por: Calabretta, Sara, et al.
Publicado: (2015) -
Combined therapy with RAD001 e BEZ235 overcomes resistance of PET immortalized cell lines to mTOR inhibition
por: Passacantilli, Ilaria, et al.
Publicado: (2014) -
The androgen receptor couples promoter recruitment of RNA processing factors to regulation of alternative polyadenylation at the 3' end of transcripts
por: Caggiano, Cinzia, et al.
Publicado: (2022) -
Combinatorial control of Spo11 alternative splicing by modulation of RNA polymerase II dynamics and splicing factor recruitment during meiosis
por: Cesari, Eleonora, et al.
Publicado: (2020) -
Exocrine Pancreatic Insufficiency in Diabetic Patients: Prevalence, Mechanisms, and Treatment
por: Piciucchi, Matteo, et al.
Publicado: (2015)